Tuoxin Pharmaceutical Group Co., Ltd, established in 2001, manufactures nucleoside and nucleotide-based active pharmaceutical ingredients and specialized reagents, with a product range spanning antiviral actives such as ribavirin, acyclovir, azvudine, and vidarabine monophosphate, as well as cytidine and adenosine derivatives including cytidylic acid, cytarabine hydrochloride, inosine, isoprinosine, and 5'-tosyladenosine. The company sells its products globally, across North America, Central and South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen